Hydralazine Hydrochloride Tablet
Product Images NDC 71335-2307

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Hydralazine Hydrochloride (NDC 71335-2307). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chem Structure (Image 01)

Chem Structure (Image 01)
Chemical structure diagram of Hydralazine Hydrochloride, showing its molecular framework including a hydrazine functional group attached to a bicyclic aromatic ring system with a hydrochloride (HCl) moiety.*
FDA Label Image

Label (Lbl713352307)

Label (Lbl713352307)
Label for Hydralazine Hydrochloride Tablets USP 10 mg, packaged as 30 tablets. The label includes the product NDC 71335-2307-1 and states it is repackaged by Bryant Ranch Prepack, Inc. and manufactured by ScieGen Pharmaceuticals, Inc. Storage and safety instructions are also present.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.